Saturday, May 30, 2026
Home Authors Posts by Ogkologos

Ogkologos

4238 POSTS 0 COMMENTS

Large DFS Benefit from Adjuvant Cemiplimab Among Patients at High Risk...

Ogkologos -
0

EMA Recommends Extension of Therapeutic Indications for Acalabrutinib

Ogkologos -
0

French Senate Committee Backs ESMO Call to Revise EU Regulation to...

Ogkologos -
0

Structured Exercise Programme Initiated Soon After the Completion of Adjuvant Chemotherapy...

Ogkologos -
0

Tarlatamab Prolongs OS Over Chemotherapy Among Patients with SCLC Whose Disease...

Ogkologos -
0

ESMO Announces Results of 2025 Elections

Ogkologos -
0

FDA Grants Accelerated Approval to Telisotuzumab Vedotin-tllv for NSCLC with High...

Ogkologos -
0

EMA Recommends Extension of Therapeutic Indications for Brentuximab Vedotin

Ogkologos -
0

ESMO Calls for Oncology-Specific Safeguards in the EU Critical Medicines Act

Ogkologos -
0

Elinzanetant Leads To a Significantly Lower Frequency of Vasomotor Symptoms Associated...

Ogkologos -
0
1...313233...424Page 32 of 424

MOST POPULAR

Load more

HOT NEWS

Follow us on Instagram @ogkologos

Το πρώτο ολοκληρωμένο portal για τον καρκίνο. Ενημερωθείτε για τον καρκίνο, καθώς και για τις τελευταίες εξελίξεις.
Contact us: info@ogkologos.com

POPULAR POSTS

POPULAR CATEGORY

Copyright © 2023 Ogkologos.com